Strong preference for “genetic sonography” as non-invasive option of prenatal diagnosis in patients with pregnancies following intracytoplasmic sperm injection

A. Geipel; Geipel A.; U. Gembruch; Gembruch U.; M. Ludwig; Ludwig M.; U. Germer; Germer U.; E. Schwinger; Schwinger E.; A. Dormeier; Dormeier A.; K. Diedrich; Diedrich K.

doi:10.17816/JOWD100912

Strong preference for “genetic sonography” as non-invasive option of prenatal diagnosis in patients with pregnancies following intracytoplasmic sperm injection

Authors: Geipel A.¹, Gembruch U.¹, Ludwig M.¹, Germer U.¹, Schwinger E.¹, Dormeier A.¹, Diedrich K.¹
Affiliations:
1. Medical University
Issue: Vol 48, No 5S (1999)
Pages: 66-66
Section: Articles
URL: https://journals.rcsi.science/jowd/article/view/100912
DOI: https://doi.org/10.17816/JOWD100912
ID: 100912

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

Objective: The option of prenatal diagnosis with nuchal translucency measurement at 10-14 weeks of gestation and second trimester targeted ultrasound including fetal echocardiography (genetic sonography) is reported in patients after intracytoplasmic sperm injection (ICSI).